Showing results (411-420 of 475) with videos related to
Sort By:
Pageof 48
Frontiers in Immunology|February 20, 2019
Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary ImmunodeficienciesRoger H Kobayashi, Sudhir Gupta, Isaac Melamed, et al.Frontiers in Immunology|January 6, 2023
Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the treatment of patients with primary immunodeficienciesRoger H Kobayashi, Sudhir Gupta, Isaac Melamed, et al.Frontiers in Immunology|November 13, 2023
Leptin favors imbalance of antigen-specific CD4+ T-cells associated with severity of cat allergyCarolina Vollmer, Aleida Dias, Marisa Sales, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasisBenjamin Weide, Henning Zelba, Evelyna Derhovanessian, et al.Journal of Leukocyte Biology|January 23, 2020
Pitfalls in the characterization of circulating and tissue-resident human γδ T cellsNicola Beucke, Daniela Wesch, Hans-Heinrich Oberg, et al.Immunity & Ageing : I & A|November 14, 2015
IL7R gene expression network associates with human healthy ageingWillemijn M Passtoors, Erik B van den Akker, Joris Deelen, et al.Oncotarget|April 23, 2016
The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parametersBarbara Brouwers, Sigrid Hatse, Lissandra Dal Lago, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2016
Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with IpilimumabAlexander Martens, Kilian Wistuba-Hamprecht, Jianda Yuan, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 10, 2018
Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label studyIsaac R Melamed, Michael Borte, Laurenz Trawnicek, et al.Journal of the American College of Cardiology|December 11, 2007
Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imagingMasayoshi Sarai, Dagmar Hartung, Artiom Petrov, et al.Pageof 48